Patented technology regarding new and safe mechanism with the active substance PH3 for the indications of osteoporosis and diabetic vascular complications. More
A number of specific PPLs, a group of prenylflavanone compounds, some novel, were isolated, identified and tested at as low as 0.04 μg/mL to be able to increase survival of neural stem cells, to promote neuronal growth with lengthening of neurite More
Ob-X is composed of herbal extracts, and reduced body and adipose tissue weight and number and size of lipid vacuoles in the liver in animal studies; reduced body weight, waist circumference and visceral fat in human studies More
A botanical drug, WH-1, has been approved for US FDA Phase II clinical trials for the treatment of diabetic foot ulcers and also potentially indicated for similar chronic wound healing management conditions. More
Western researchers have developed a novel technique, Swallowing Air-Pulse Therapy (SWAPT) and an associated device Swallowing Air-Pulse Therapy System (SWAPTS). More
A fermented soymilk extract, MS-20, is in Phase II (US FDA and Taiwan DOH) and Phase III (Taiwan DOH) clinical trials for the treatment of cachexia in liver cancer patients and for reducing neutropenic fever in cancer patients undergoing chemotherapy More
Patented technology regarding a superior adjuvant with the active substance polysaccharide for oral/nasal vaccines against influenza and bird influenza, targeted to the aging population. More
Displaying 1..10 of 24 -
per page
Next page
Order by
All rights reserved. Terms and Conditions | Contact us
